中财网 中财网股票行情
博瑞医药(688166)财务分析指标    年份：
截止日期2025-12-312025-09-302025-06-302025-03-312024-12-31
营业总收入(万元)122364.0187424.9753743.8724895.98128255.16
营业收入(万元)122364.0187424.9753743.8724895.98128255.16
营业总成本(万元)124211.3085930.1154954.2426656.00110259.87
营业成本(万元)60161.1642492.6727566.5613955.3054495.08
净利润(万元)9119.124774.031459.351288.9615133.36
归属于母公司的净利润(万元)5451.475032.001717.321295.9818916.69
营业利润(万元)1466.412277.33-482.21-1189.6416028.90
利润总额(万元)1390.882241.48-502.12-1186.3915720.06
少数股东损益(万元)-1756.04-1893.35-1551.61-1761.65-4790.37
基本每股收益(元)0.13(元)0.12(元)0.04(元)0.03(元)0.45(元)
稀释每股收益(元)0.13(元)0.12(元)0.04(元)0.03(元)0.45(元)
非经常性损益(万元)2842.53414.78280.46--865.94
扣除非经常性损益后净利润(万元)2608.944617.231436.86803.3818050.75
总资产(万元)582484.17536007.00538379.46528527.33516434.62
总负债(万元)297866.62282835.16279762.76266925.64272697.03
归属于母公司股东权益合计(万元)252116.68244804.22247431.67250161.88239464.76
股东权益合计(万元)284617.55253171.84258616.69261601.69243737.59
实收资本(股本)(万元)42310.3942310.2542276.8242246.6642246.66
资本公积(万元)107609.75103637.72109452.68107644.4798236.30
未分配利润(万元)96766.0997597.2494282.5697379.9096083.92
经营活动产生的现金流量净额(万元)32519.089895.4911361.2810699.3024555.93
经营活动现金流入小计(万元)125408.4182217.7956239.2031790.72111787.06
经营活动现金流出小计(万元)92889.3372322.3144877.9221091.4287231.13
投资活动产生的现金流量净额(万元)-62254.45-55256.91-38730.26-22729.76-44014.15
投资活动现金流入小计(万元)9080.844672.434672.280.6215584.16
投资活动现金流出小计(万元)71335.2959929.3443402.5422730.3859598.31
筹资活动产生的现金流量净额(万元)49765.2529366.5924411.1116939.10-2447.49
筹资活动现金流入小计(万元)153984.8196500.2974869.9351815.1992607.71
筹资活动现金流出小计(万元)104219.5667133.7050458.8234876.0995055.20
期末现金及现金等价物余额(万元)95506.3360021.6473083.3280631.1375410.19
最后修改日期2026-03-212025-11-012025-08-292025-04-172025-04-03
↑返回页顶↑

转至博瑞医药（688166）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。